Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.
暂无分享,去创建一个
S. Tura | G. Visani | A. de Vivo | D. Rondelli | F. Lauria | D. Raspadori | A. de Vivo | M. Ventura
[1] G. Janossy,et al. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). , 1996, Blood.
[2] B. Drénou,et al. P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML). , 1994, Leukemia.
[3] T. Holyoake,et al. CD34+ positive haemopoietic cells: biology and clinical applications. , 1994, Blood reviews.
[4] S. Tura,et al. Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator. , 1994 .
[5] P. Sonneveld,et al. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. , 1993, Blood.
[6] J. Magaud,et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. , 1993, Blood.
[7] A. Pascarella,et al. CD34 expression fails to predict the outcome in adult acute myeloid leukemia. , 1993, Haematologica.
[8] E. Thiel,et al. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. , 1993, Leukemia.
[9] N. Lucie,et al. The prognostic significance of the CD34 antigen in acute myeloid leukaemia. , 1992, Leukemia & lymphoma.
[10] J. Griffin,et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. , 1991, Blood.
[11] S. Piantadosi,et al. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10) , 1990, British journal of haematology.
[12] M. Greaves,et al. The hemopoietic stem cell antigen, CD34, is encoded by a gene located on chromosome 1. , 1989, Leukemia.
[13] D. Treille,et al. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy , 1989, British journal of haematology.
[14] S. Bigner,et al. Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. , 1989, American journal of clinical pathology.
[15] D. Weisenburger,et al. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). , 1988, Leukemia.
[16] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[17] M. Fackler,et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. , 1984, Journal of immunology.
[18] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[19] S. Tura,et al. The presence of lymphoid‐associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance , 1995, Stem cells.
[20] F. Lanza,et al. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. , 1994, Leukemia & lymphoma.
[21] C. Civin,et al. Antigenic analysis of hematopoiesis: a review. , 1993, Journal of hematotherapy.